Antibody-Drug Conjugates in NSCLC: Update on TROPION-PanTumor01 Data

home / news-network / antibody-drug-conjugates-in-nsclc-update-on-tropion-pantumor01-data

Rebecca Suk Heist, MD, MPH, and Solange Peters, MD, PhD, discuss data updates from the TROPION-PanTumor01 study that impact the use of antibody-drug conjugates as a therapy option for patients with second-line metastatic non-small cell lung cancer.